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Dear Editor, 
 
It has been suggested that genes are distributed non-randomly on human chromosomes 
(Hecht, 1988; Lima-de-Faria and Mitelman, 1988; Lima-de-Faria et al., 1991; Mouchiroud et 
al., 1991; Saccone et al., 1992; 1996; Musio et al., 2002; Rafiee et al., 2008). Recently we re-
ported that polymorphic loci associated with susceptibility to either breast cancer (Saify and 
Saadat, 2012) or schizophrenia (Saadat, 2013) are non-randomly distributed on some human 
chromosome segments. 
It is well established that Parkinson's disease (PD) is a complex multifactorial neuro-
degenerative disease that was considered the result of environmental and genetic factors 
(Siderowf, 2001; Warner and Schapira, 2003; Allam et al., 2005; Trinh and Farrer, 2013). 
Based on familial aggregation studies and the study of twins, it has been established that ge-
netic elements have significant roles in the development of multiple sclerosis (MS) (Ascherio, 
2013; Cree, 2014). 
Several meta-analyses based on genetic polymorphisms have been widely performed to 
assess the association between particular gene variants and PD or MS risk. Some of these 
studies were indicating that the study polymorphisms were not associated with the risks of PD 
or MS. However, in other studies significant associations with risks of PD or MS, at least in a 
specific ethnic group were reported (Lill et al., 2012a; b). Taken together, we suggested that 
loci associated with the risk of PD or MS may be distributed non-randomly on human chro-
mosomes. Therefore the present study was carried out. 
Meta-analysis studies published up to February 2014 with information of genetic poly-
morphisms and PD risk were identified using Parkinson's Disease Research Forum (PDGene 
database http://www.pdgene.org) electronic database (Lill et al., 2012a). Information of genetic 
polymorphisms and MS risk was identified using MSGene database (http://www.msgene.org) 
electronic database (Lill et al., 2012b).  
To evaluate the non-randomness distribution of susceptible loci on each chromosomal 
band(s) the method of Tai et al. (1993) was used. The relative width of each band was meas-
ured using the diagram of the International System for Chromosome Nomenclature (ISCN, 
1981). A probability of P<0.05 was considered statistically significant. 
There were 881 studies concerning the associations between 915 genes (3446 polymor-
phisms) and risk of PD. Table 1 shows the genes with their genetic polymorphisms associated 
with susceptibility to PD in at least one ethnic group. There are 20 loci associated with risk of 
PD. Statistical analysis revealed that the PD susceptible loci distributed non-randomly on hu-
man chromosomes. Human chromosome segments 1q31-1q32 (P<0.001) and 17q21-q23 
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(P<0.001) were bearing significantly higher numbers of susceptible loci for PD. There are 
four genes which associated with susceptibility to PD on 1q31-q32 (SLC45A3, NUCKS1, 
SLC41A1, and PM20D1/ PARK16). There are three genes which associated with susceptibil-
ity to PD on 17q21-q23 (PLEKHM1, MAPT, and MED13).  
There were 789 studies concerning the associations between 809 genes (2907 polymor-
phisms) and susceptibility to MS. Table 2 shows the genes with their genetic polymorphisms 
associated with risk of MS in at least one ethnic group. There are 44 loci associated with MS 
risk. Statistical analysis revealed that the MS susceptible loci distributed non-randomly on 
human chromosomes. Human chromosome segments 1p22, 5p13, 17q12-21.2, 19p13, and 
19q13 (P<0.001) were bearing significantly higher numbers of susceptible loci for MS. There 
are four genes which associated with MS risk on 5p13 (IL7R, PTGER4, C7, and HEATR7B2). 
There are three genes which associated with susceptibility to MS on each chromosomal seg-
ments of 1p22 (EVI5, RPL5, and FAM69A), 17q12-21.2 (CCL8, CCL1, and STAT), 19p13 
(VAV1, TYK2, and IFI30) and 19q13 (TGFB1, APOE, and LILRA3). 
Already the non-random distributions of polymorphic loci associated with both breast 
cancer (Saify and Saadat, 2012) and schizophrenia (Saadat, 2013), were reported. A mass 
screening test might be designed using genes located on above mentioned chromosome seg-
ments for diagnosis of PD and MS. It is suggested that using simultaneously polymorphisms 
of the genes located on the above mentioned chromosome segment can increase the sensitivi-
ty and specificity of the mass screening test for detecting high risk individuals for developing 
Parkinson's disease and multiple sclerosis. 
 
 
 
Table 1: List of genes that associated with Parkinson's disease risk 
Gene Symbol Location OMIM 
CCDC21 1p36.1 - 
GBA 1q21 606463 
SLC45A3 1q32.1 605097 
NUCKS1 1q32.1 611912 
SLC41A1 1q31-q32 610801 
PM20D1/PARK16 1q32 613164 
STK39 2q24.3 607648 
ACMSD (NR4A2) 2q22-q23 601828 
MCCC1 3q25-q27 609010 
GAK 4p16 602052 
DGKQ 4p16.3 601207 
BST1 4p15.32 600387 
SNCA 4q21 163890 
MMRN1 4q22.1 601456 
HLA-DRB5 6p21.3 604776 
LRRK2 12q12 609007 
PLEKHM1 17q21.3 611466 
MAPT 17q21.1 157140 
MED13 17q22-q23 603808 
MAOB Xp11.23 309860 
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Table 2: List of genes that associated with multiple sclerosis risk 
Gene symbol Location OMIM 
MMEL1 1p36.3 - 
EVI5 1p22 602942 
RPL5 1p22.1 603634 
FAM69A 1p22.1 614542 
CD58 1p13 153420 
FCRL3 1q21.2-q22 606510 
RGS1 1q31 600323 
KIF21B 1q31-q32 608322 
SLC4A5 2p13 606757 
CXCR4 2q21 162643 
CBLB 3q13.11 604491 
TMEM39A 3q21.1 - 
IL12A 3q25.33 161560 
CXCL10 4q21 147310 
IL7R 5p13 146661 
PTGER4 5p13.1 601586 
C7 5p13 217070 
HEATR7B2 5p13.2 - 
HLA-DRB1 6p21.3 142857 
OLIG3 6q23.3 609323 
IL7 8q21.12 146660 
IL2RA 10p15.1 147730 
CHUK 10q24 600664 
INPP5A 10q26.3 600106 
CD6 11q12.2 186720 
TNFRSF1A 12p13.31 191190 
KLRB1 12p13.31 602890 
CYP27B1 12q13.1-q13.3 609506 
SH2B3 12q24.12 605093 
MPHOSPH9 12q24.31 605501 
RGMA 15q26.1 607362 
CLEC16A 16p13.13 611303 
IL21R 16p12.1 605383 
CCL8 17q12 602283 
CCL1 17q12 182281 
STAT3 17q21.2 102582 
CD226 18q22.2 605397 
VAV1 19p13.3 164875 
TYK2 19p13.2 176941 
IFI30 19p13.11 604664 
TGFB1 19q13.2 190180 
APOE 19q13.32 107741 
LILRA3 19q13.42 604818 
CD40 20q12-q13.2 109535 
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